Meinian Onehealth Hits Day Low of CNY 6.36 Amid Price Pressure

Meinian Onehealth Healthcare Holdings Co., Ltd. experienced significant volatility on March 3, 2026, with the stock declining by 9.22% and reaching an intraday low of CNY 6.36. This performance starkly contrasts with the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, Meinian Onehealth has seen a decrease of 3.61%, while its monthly performance reflects a decline of 10.86%. Despite a modest annual gain of 0.31%, the stock has struggled over longer periods, with a three-year performance down by 5.6% and a staggering 63.18% drop over the past five and ten years. Financial metrics indicate a challenging landscape for the company, highlighted by a debt-to-equity ratio of 0.28 and a return on equity of 4.95%. The latest quarterly results revealed a net profit of CNY -275.29 million, marking a significant decline of 493.29%. Additionally, raw material costs have increased by 13.32% year-over-year, further impacting profitability. The current market capitalization stands at CNY 26,659 million, reflecting its large-cap status within the pharmaceuticals and biotechnology industry.